ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Dnae Oncology Limited

Dnae Oncology Limited is an active company incorporated on 2 September 2015 with the registered office located in London, Greater London. Dnae Oncology Limited was registered 10 years ago.
Status
Active
Active since incorporation
Company No
09758933
Private limited company
Age
10 years
Incorporated 2 September 2015
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Due Soon
Dated 1 September 2024 (1 year ago)
Next confirmation dated 1 September 2025
Due by 15 September 2025 (7 days remaining)
Last change occurred 8 years ago
Accounts
Due Soon
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Audit Exemption Subsidiary
Next accounts for period 31 December 2024
Due by 30 September 2025 (22 days remaining)
Contact
Address
Scale Space
58 Wood Lane
London
W12 7RZ
England
Same address for the past 4 years
Telephone
020 70362100
Email
Unreported
Website
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Professor • British • Lives in UK • Born in Jul 1961
Director • President, Coo And Executive Director • Malaysian • Lives in Malaysia • Born in May 1965
Dnae Group Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Dnae Diagnostics Limited
Kong Han Tan and Christofer Toumazou are mutual people.
Active
Dnae Group Holdings Limited
Christofer Toumazou is a mutual person.
Active
Owlstone Medical Limited
Christofer Toumazou is a mutual person.
Active
Dnae Thermal Limited
Kong Han Tan and Christofer Toumazou are mutual people.
Dissolved
Dnanudge Limited
Christofer Toumazou is a mutual person.
In Administration
Financials
Net Assets, Total Assets & Total Liabilities (2016–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
2
Same as previous period
Total Assets
£0
Same as previous period
Total Liabilities
-£5.64M
Increased by £215.12K (+4%)
Net Assets
-£5.64M
Decreased by £215.12K (+4%)
Debt Ratio (%)
Unreported
Latest Activity
Subsidiary Accounts Submitted
11 Months Ago on 14 Sep 2024
Confirmation Submitted
1 Year Ago on 3 Sep 2024
Subsidiary Accounts Submitted
1 Year 9 Months Ago on 24 Nov 2023
Confirmation Submitted
2 Years Ago on 7 Sep 2023
Subsidiary Accounts Submitted
2 Years 6 Months Ago on 22 Feb 2023
Confirmation Submitted
3 Years Ago on 5 Sep 2022
Small Accounts Submitted
3 Years Ago on 12 Jul 2022
Confirmation Submitted
4 Years Ago on 6 Sep 2021
Registered Address Changed
4 Years Ago on 3 Jan 2021
Small Accounts Submitted
4 Years Ago on 24 Dec 2020
Get Credit Report
Discover Dnae Oncology Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
Submitted on 14 Sep 2024
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
Submitted on 14 Sep 2024
Audit exemption statement of guarantee by parent company for period ending 31/12/23
Submitted on 14 Sep 2024
Audit exemption subsidiary accounts made up to 31 December 2023
Submitted on 14 Sep 2024
Confirmation statement made on 1 September 2024 with no updates
Submitted on 3 Sep 2024
Audit exemption subsidiary accounts made up to 31 December 2022
Submitted on 24 Nov 2023
Notice of agreement to exemption from audit of accounts for period ending 31/12/22
Submitted on 24 Nov 2023
Consolidated accounts of parent company for subsidiary company period ending 31/12/22
Submitted on 24 Nov 2023
Audit exemption statement of guarantee by parent company for period ending 31/12/22
Submitted on 24 Nov 2023
Notice of agreement to exemption from audit of accounts for period ending 31/12/22
Submitted on 28 Oct 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year